Press Release Archive
Press Releases
June 2022
06.14.2022
Prescription Medicines Medicines Pfizer Reports Additional Data on PAXLOVID™ Supporting Upcoming New Drug Application Submission to U.S. FDA
06.09.2022
Financial Investments Pfizer Completes Acquisition of ReViral
06.09.2022
06.08.2022
06.06.2022
Financial Covid-19 Investments Vaccines Pfizer to Invest $120 Million to Produce COVID-19 Oral Treatment in the U.S.
06.05.2022
06.04.2022
06.02.2022
06.01.2022
06.01.2022
May 2022
05.31.2022
05.26.2022
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits.
However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may only respond to calls and emails from professional journalists.